Clinical Trial Update: Baduanjin Versus Brisk Walking for Cognition in Schizophrenia [NA]

View source ↗

Summary

This clinical trial update reports completion of a study comparing Baduanjin to brisk walking to assess cognitive outcomes in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Schizophrenia, Exercise | NA | Status: COMPLETED